JUNSHI BIOSCIENCES ANNOUNCES ACCEPTANCE OF THE NDA FOR ROCONKIBART (IL-17A) FOR THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS

Reuters · 1d ago

Please log in to view news